‘WHO’ points out for Dexamethasone Treat severe COVID cases

17 October 2020


World Health Organization (WHO) pointed out Dexamethasone It’s the only drug that can treat severe COVID cases.

Xinhua news agency reported that On Friday (16 Oct.) World Health Organization (WHO) has released the latest results from four international trials of the drug to treat COVID-19 indicating that The drug is effective “Little or no” in preventing death or shortening hospitalization time.

WHO Has stopped the trial of hydroxychloroquine. (Hydroxychloroquine) in June the past. This included Lopinavir, which was co-administered with Ritonavir in July, indicating that treatment with the drug reduced mortality in patients. COVID-19 In the hospital only a small amount

“The current results of the experiment also indicate that The other two drugs, Remdesivir and Interferon, had little or no effect in preventing death or reducing hospitalization time. ” WHO Director-General Tedros Adhanom Ghebrijesus said, adding: The results were obtained from the Solidarity Trial, which is governed by WHO.

Dr Tedros said the trial is still accepting approximately 2,000 patients per month and will assess alternative therapies. This includes a monoclonal antibody and a new antiviral drug.

“At this time, Dexamethasone (Dexamethasone) corticosteroid group (Corticosteroids) remain the only effective drug against COVID-19. For patients with severe symptoms, “Dr. Tedros said, anticipating that Full results of the experiment will be published soon in leading science journals.

The Solidarity Trial project, which was launched in March last year. Is an experimental treatment for COVID-19 World’s Largest Random Nearly 13,000 patients from 500 hospitals in 30 countries participated in the trial.

As the world struggles to control that pandemic Countries around the world, such as France, Italy, China, Russia, the United Kingdom and the United States, are seeking a vaccine. Worldwide, 198 vaccines are developing against COVID-19, according to the WHO website, and as of Oct. 15, 42 vaccines are in clinical trials.


Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.